FDA Approves Two Drugs, Companion Diagnostic Test for Advanced Skin Cancer

. . No comments:
The U.S. Food and Drug Administration today approved two new drugs, Tafinlar  (dabrafenib) and  Mekinist  (trametinib), for patients with ad...

Cancer Research UK installs Flexicon FP50

. . No comments:
Cancer Research UK Biotherapeutics Development Unit (BDU) has installed a Flexicon FP50 tabletop filling and stoppering machine from Watson ...

Drug resistance may make malaria parasites vulnerable to other substances

. . No comments:
Malaria parasites that develop resistance to the most effective class of anti-malarial drugs may become susceptible to other treatments as a...

Capsugel launches Lipidex technology platform

. . No comments:
US dosage forms specialist Capsugel will launch its Lipidex technology platform this month (June), which integrates the firm’s lipid, liquid...

Bió-Phārmā

Bió-Phārmā is the field of study concerning BioPharmaceuticals, Medical Drugs produced using Biotechnology. Bió-Phārmā, the company with the goal to be versatile in the field of Information Services contains searches, information, news, blogs, reviews, articles, videos and resources related links for the community of Pharmaceutical, Biotechnology, Healthcare and Medical-related Professionals & Industry.

Powered by Blogger.
All Science Sites